Drug Shortage Report for TELMISARTAN
Report ID | 69049 |
Drug Identification Number | 02390353 |
Brand name | TELMISARTAN |
Common or Proper name | TELMISARTAN |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | TELMISARTAN |
Strength(s) | 80MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2019-01-21 |
Actual start date | 2019-01-25 |
Estimated end date | 2019-05-29 |
Actual end date | 2019-05-29 |
Shortage status | Resolved |
Updated date | 2019-05-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v27 | 2019-05-31 | French | Compare |
v26 | 2019-05-31 | English | Compare |
v25 | 2019-05-27 | French | Compare |
v24 | 2019-05-27 | English | Compare |
v23 | 2019-05-13 | French | Compare |
v22 | 2019-05-13 | English | Compare |
v21 | 2019-04-29 | French | Compare |
v20 | 2019-04-29 | English | Compare |
v19 | 2019-04-22 | French | Compare |
v18 | 2019-04-22 | English | Compare |
v17 | 2019-03-25 | French | Compare |
v16 | 2019-03-25 | English | Compare |
v15 | 2019-03-11 | French | Compare |
v14 | 2019-03-11 | English | Compare |
v13 | 2019-02-15 | French | Compare |
v12 | 2019-02-15 | English | Compare |
v11 | 2019-01-28 | French | Compare |
v10 | 2019-01-28 | English | Compare |
v9 | 2019-01-22 | English | Compare |
v8 | 2019-01-07 | French | Compare |